Annual Cash & Cash Equivalents
$12.78 M
+$1.12 M+9.59%
December 31, 2023
Summary
- As of February 7, 2025, VINC annual cash & cash equivalents is $12.78 million, with the most recent change of +$1.12 million (+9.59%) on December 31, 2023.
- During the last 3 years, VINC annual cash & cash equivalents has fallen by -$49.01 million (-79.31%).
- VINC annual cash & cash equivalents is now -88.53% below its all-time high of $111.46 million, reached on December 31, 2021.
Performance
VINC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.94 M
-$4.98 M-62.87%
September 30, 2024
Summary
- As of February 7, 2025, VINC quarterly cash and cash equivalents is $2.94 million, with the most recent change of -$4.98 million (-62.87%) on September 30, 2024.
- Over the past year, VINC quarterly cash and cash equivalents has dropped by -$9.84 million (-76.98%).
- VINC quarterly cash and cash equivalents is now -97.60% below its all-time high of $122.80 million, reached on September 30, 2021.
Performance
VINC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VINC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.6% | -77.0% |
| 3 y3 years | -79.3% | -97.0% |
| 5 y5 years | +100.0% | -95.1% |
VINC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.5% | +9.6% | -97.4% | at low |
| 5 y | 5-year | -88.5% | -100.0% | -97.6% | at low |
| alltime | all time | -88.5% | -100.0% | -97.6% | at low |
Vincerx Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.94 M(-62.9%) |
| Jun 2024 | - | $7.92 M(+55.0%) |
| Mar 2024 | - | $5.11 M(-60.0%) |
| Dec 2023 | $12.78 M(+9.6%) | $12.78 M(-15.2%) |
| Sep 2023 | - | $15.08 M(+125.8%) |
| Jun 2023 | - | $6.68 M(+48.8%) |
| Mar 2023 | - | $4.49 M(-61.5%) |
| Dec 2022 | $11.66 M | $11.66 M(-74.5%) |
| Sep 2022 | - | $45.80 M(-43.4%) |
| Jun 2022 | - | $80.86 M(-16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $96.49 M(-13.4%) |
| Dec 2021 | $111.46 M(+80.4%) | $111.46 M(-9.2%) |
| Sep 2021 | - | $122.80 M(+43.4%) |
| Jun 2021 | - | $85.62 M(+60.5%) |
| Mar 2021 | - | $53.35 M(-13.7%) |
| Dec 2020 | $61.79 M(>+9900.0%) | $61.79 M(-37.9%) |
| Sep 2020 | - | $99.43 M(+32.2%) |
| Jun 2020 | - | $75.22 M(+25.2%) |
| Dec 2019 | $0.00 | - |
| Dec 2019 | - | $60.07 M |
FAQ
- What is Vincerx Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vincerx Pharma?
- What is Vincerx Pharma annual cash & cash equivalents year-on-year change?
- What is Vincerx Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Vincerx Pharma?
- What is Vincerx Pharma quarterly cash and cash equivalents year-on-year change?
What is Vincerx Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of VINC is $12.78 M
What is the all time high annual cash & cash equivalents for Vincerx Pharma?
Vincerx Pharma all-time high annual cash & cash equivalents is $111.46 M
What is Vincerx Pharma annual cash & cash equivalents year-on-year change?
Over the past year, VINC annual cash & cash equivalents has changed by +$1.12 M (+9.59%)
What is Vincerx Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VINC is $2.94 M
What is the all time high quarterly cash and cash equivalents for Vincerx Pharma?
Vincerx Pharma all-time high quarterly cash and cash equivalents is $122.80 M
What is Vincerx Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, VINC quarterly cash and cash equivalents has changed by -$9.84 M (-76.98%)